Abstract
Medulloblastoma, the most common malignant childhood brain tumor, exhibits distinct molecular subtypes and cellular origins. Genetic alterations driving medulloblastoma initiation and progression remain poorly understood. Herein, we identify GNAS, encoding the G protein Gαs, as a potent tumor suppressor gene that, when expressed at low levels, defines a subset of aggressive Sonic hedgehog (SHH)-driven human medulloblastomas. Ablation of the single Gnas gene in anatomically distinct progenitors in mice is sufficient to induce Shh-associated medulloblastomas, which recapitulate their human counterparts. Gαs is highly enriched at the primary cilium of granule neuron precursors and suppresses Shh signaling by regulating both the cAMP-dependent pathway and ciliary trafficking of Hedgehog pathway components. Elevation in levels of a Gαs effector, cAMP, effectively inhibits tumor cell proliferation and progression in Gnas-ablated mice. Thus, our gain- and loss-of-function studies identify a previously unrecognized tumor suppressor function for Gαs that can be found consistently across Shh-group medulloblastomas of disparate cellular and anatomical origins, highlighting G protein modulation as a potential therapeutic avenue.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Taylor, M.D. et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 123, 465–472 (2012).
Northcott, P.A. et al. Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathol. 122, 231–240 (2011).
Grammel, D. et al. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Acta Neuropathol. 123, 601–614 (2012).
Sasai, K. et al. Medulloblastomas derived from Cxcr6 mutant mice respond to treatment with a smoothened inhibitor. Cancer Res. 67, 3871–3877 (2007).
Kool, M. et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to Smoothened inhibition. Cancer Cell 25, 393–405 (2014).
Niewiadomski, P., Zhujiang, A., Youssef, M. & Waschek, J.A. Interaction of PACAP with Sonic hedgehog reveals complex regulation of the hedgehog pathway by PKA. Cell. Signal. 25, 2222–2230 (2013).
Neves, S.R., Ram, P.T. & Iyengar, R. G protein pathways. Science 296, 1636–1639 (2002).
Kan, Z. et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466, 869–873 (2010).
Huh, J.Y. et al. Novel nonsense GNAS mutation in a 14-month-old boy with plate-like osteoma cutis and medulloblastoma. J. Dermatol. 41, 319–321 (2014).
Cho, Y.J. et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J. Clin. Oncol. 29, 1424–1430 (2011).
Remke, M. et al. Adult medulloblastoma comprises three major molecular variants. J. Clin. Oncol. 29, 2717–2723 (2011).
Remke, M. et al. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. J. Clin. Oncol. 29, 3852–3861 (2011).
Yang, Z.J. et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 14, 135–145 (2008).
Zhuo, L. et al. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis 31, 85–94 (2001).
Northcott, P.A., Korshunov, A., Pfister, S.M. & Taylor, M.D. The clinical implications of medulloblastoma subgroups. Nat. Rev. Neurol. 8, 340–351 (2012).
Regard, J.B. et al. Wnt/β-catenin signaling is differentially regulated by Gα proteins and contributes to fibrous dysplasia. Proc. Natl. Acad. Sci. USA 108, 20101–20106 (2011).
Lu, Q.R. et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109, 75–86 (2002).
Hohenegger, M. et al. Gsα-selective G protein antagonists. Proc. Natl. Acad. Sci. USA 95, 346–351 (1998).
Graziano, M.P. & Gilman, A.G. Synthesis in Escherichia coli of GTPase-deficient mutants of Gs alpha. J. Biol. Chem. 264, 15475–15482 (1989).
Dorsam, R.T. & Gutkind, J.S. G-protein–coupled receptors and cancer. Nat. Rev. Cancer 7, 79–94 (2007).
Tuson, M., He, M. & Anderson, K.V. Protein kinase A acts at the basal body of the primary cilium to prevent Gli2 activation and ventralization of the mouse neural tube. Development 138, 4921–4930 (2011).
Nozawa, Y.I., Lin, C. & Chuang, P.T. Hedgehog signaling from the primary cilium to the nucleus: an emerging picture of ciliary localization, trafficking and transduction. Curr. Opin. Genet. Dev. 23, 429–437 (2013).
Pan, Y., Wang, C. & Wang, B. Phosphorylation of Gli2 by protein kinase A is required for Gli2 processing and degradation and the Sonic Hedgehog-regulated mouse development. Dev. Biol. 326, 177–189 (2009).
Nikulina, E., Tidwell, J.L., Dai, H.N., Bregman, B.S. & Filbin, M.T. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc. Natl. Acad. Sci. USA 101, 8786–8790 (2004).
Conti, M. & Jin, S.L. The molecular biology of cyclic nucleotide phosphodiesterases. Prog. Nucleic Acid Res. Mol. Biol. 63, 1–38 (1999).
Wang, B., Fallon, J.F. & Beachy, P.A. Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 100, 423–434 (2000).
Ruiz i Altaba, A., Mas, C. & Stecca, B. The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends Cell Biol. 17, 438–447 (2007).
Regard, J.B. et al. Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification. Nat. Med. 19, 1505–1512 (2013).
Mukhopadhyay, S. et al. The ciliary G-protein–coupled receptor Gpr161 negatively regulates the Sonic hedgehog pathway via cAMP signaling. Cell 152, 210–223 (2013).
Yang, L. et al. Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Res. 67, 651–658 (2007).
Rohatgi, R., Milenkovic, L. & Scott, M.P. Patched1 regulates hedgehog signaling at the primary cilium. Science 317, 372–376 (2007).
Goetz, S.C., Ocbina, P.J. & Anderson, K.V. The primary cilium as a Hedgehog signal transduction machine. Methods Cell Biol. 94, 199–222 (2009).
Chen, J.K., Taipale, J., Young, K.E., Maiti, T. & Beachy, P.A. Small molecule modulation of Smoothened activity. Proc. Natl. Acad. Sci. USA 99, 14071–14076 (2002).
Dijkgraaf, G.J. et al. Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance. Cancer Res. 71, 435–444 (2011).
Schüller, U. et al. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 14, 123–134 (2008).
Xin, M. et al. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J. Neurosci. 25, 1354–1365 (2005).
Lu, Q.R. et al. Sonic hedgehog–regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 25, 317–329 (2000).
Machold, R., Klein, C. & Fishell, G. Genes expressed in Atoh1 neuronal lineages arising from the r1/isthmus rhombic lip. Gene Expr. Patterns 11, 349–359 (2011).
Gibson, P. et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 468, 1095–1099 (2010).
Gilbertson, R.J. & Ellison, D.W. The origins of medulloblastoma subtypes. Annu. Rev. Pathol. 3, 341–365 (2008).
Pounds, S. et al. A procedure to statistically evaluate agreement of differential expression for cross-species genomics. Bioinformatics 27, 2098–2103 (2011).
Tibshirani, R., Hastie, T., Narasimhan, B. & Chu, G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. USA 99, 6567–6572 (2002).
Sengupta, R. et al. CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma. Cancer Res. 72, 122–132 (2012).
Northcott, P.A. et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488, 49–56 (2012).
Mishra, P.K. et al. Misregulation of Scm3p/HJURP causes chromosome instability in Saccharomyces cerevisiae and human cells. PLoS Genet. 7, e1002303 (2011).
Dunleavy, E.M. et al. HJURP is a cell-cycle–dependent maintenance and deposition factor of CENP-A at centromeres. Cell 137, 485–497 (2009).
Parsons, D.W. et al. The genetic landscape of the childhood cancer medulloblastoma. Science 331, 435–439 (2011).
Silbereis, J.C. et al. Olig1 function is required to repress dlx1/2 and interneuron production in Mammalian brain. Neuron 81, 574–587 (2014).
O'Hayre, M. et al. The emerging mutational landscape of G proteins and G-protein–coupled receptors in cancer. Nat. Rev. Cancer 13, 412–424 (2013).
Romer, J.T. et al. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1+/−p53−/− mice. Cancer Cell 6, 229–240 (2004).
Yauch, R.L. et al. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326, 572–574 (2009).
Sengupta, R., Sun, T., Warrington, N.M. & Rubin, J.B. Treating brain tumors with PDE4 inhibitors. Trends Pharmacol. Sci. 32, 337–344 (2011).
Chahar, M.K., Sharma, N., Dobhal, M.P. & Joshi, Y.C. Flavonoids: A versatile source of anticancer drugs. Pharmacogn. Rev. 5, 1–12 (2011).
Nikaido, T. et al. Inhibition of adenosine 3′,5′-cyclic monophosphate phosphodiesterase by flavonoids. III. Chem. Pharm. Bull. (Tokyo) 37, 1392–1395 (1989).
Ng, J.M. & Curran, T. The Hedgehog's tale: developing strategies for targeting cancer. Nat. Rev. Cancer 11, 493–501 (2011).
Chen, M. et al. Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gsα deficiency. J. Clin. Invest. 115, 3217–3227 (2005).
Northcott, P.A. et al. Medulloblastoma comprises four distinct molecular variants. J. Clin. Oncol. 29, 1408–1414 (2011).
Northcott, P.A. et al. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol. 123, 615–626 (2012).
Carvalho, B.S. & Irizarry, R.A. A framework for oligonucleotide microarray preprocessing. Bioinformatics 26, 2363–2367 (2010).
Vilella, A.J. et al. EnsemblCompara GeneTrees: Complete, duplication-aware phylogenetic trees in vertebrates. Genome Res. 19, 327–335 (2009).
Acknowledgements
We would like to thank A. Gilman, L. Lum, E. Hurlock, K. Campbell, J. Chan, H. Li, A. Hassan, D. He, E. Lu, L. He and W. Ding for comments and technical support. We thank B. Fritzsch (University of Iowa) and J. Johnson (UT Southwestern) for Atoh1-Cre and Atoh1-GFP lines, respectively, C. Stiles (Harvard Medical School) for anti-Olig2, R. Rohatgi (Stanford University) for Ptch1-specific antibody and S. Scales (Genentech) for Gli2-, Gli3- and GPR161-specific antibodies. This study was funded in part by grants from the US National Institutes of Health (R01 NS078092 and R01 NS075243) to Q.R.L., the Ministry of Education of China (IRT0935) and from the Canadian Institutes of Health Research to M.D.T. and a postdoctoral fellowship by the Mildred-Scheel Foundation/German Cancer Aid (M.R.).
Author information
Authors and Affiliations
Contributions
X.H. and Q.R.L. designed the experiments, analyzed the data and wrote the manuscript with input from all authors. X.H., L.Z., Y.C., M.R., D.S., F.L., H.W., Y.Y., Y.X., Y.D., V.R., X.W. and T.H. carried out the in vitro, in vivo, gene profiling or in silico studies. M.K. and S.M.P. provided whole-genome sequencing data. Y.H., F.W. and W.Z. provided resources and supervision. L.S.W. provided the Gnas floxed mice. D.K.B. and S.H.K. diagnosed and confirmed the GNAS-mutated MB. S.L.P., R.J.G., J.B.R. and R.W.-R. provided conceptual advice and edited the manuscript. M.D.T. and Q.R.L. supervised the project.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–14 (PDF 5541 kb)
Supplementary Table 1
GNAS mutations in SHH medulloblastomas (XLSX 11 kb)
Rights and permissions
About this article
Cite this article
He, X., Zhang, L., Chen, Y. et al. The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog−driven medulloblastoma. Nat Med 20, 1035–1042 (2014). https://doi.org/10.1038/nm.3666
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3666
This article is cited by
-
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Journal of Hematology & Oncology (2024)
-
Exceptionally rare IDH1-mutant adult medulloblastoma with concurrent GNAS mutation revealed by in vivo magnetic resonance spectroscopy and deep sequencing
Acta Neuropathologica Communications (2023)
-
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability
Nature Communications (2023)
-
Current status of molecular diagnostic approaches using liquid biopsy
Journal of Gastroenterology (2023)
-
Lysophosphatidic acid receptor 6 regulated by miR-27a-3p attenuates tumor proliferation in breast cancer
Clinical and Translational Oncology (2022)